V type and/or x type spla2 inhibitors

摘要

V type and/or X type sPLA2 inhibitors which contain as the active ingredient compounds represented by general formulae (A), (B), (C), prodrugs thereof, pharmaceutically acceptable salts of the same or solvates of the same, wherein R<1>, R<2>, R<3> and R<4> independently represent each hydrogen, a non-interfering substituent, etc.; R<5> represents a carbon ring, a heterocycle, etc.; R<6> represents hydrogen, C1-3 alkyl, etc.; R represents -COCONH2, etc.; and R represents -CONH2, etc.